Kerry Wentworth
About Kerry Wentworth
Chief Regulatory Officer at Nuvation Bio
Kerry Wentworth joined Nuvation Bio as Chief Regulatory Officer in 2022. With over 25 years of experience in Regulatory and Quality Affairs, she brings extensive expertise in both domestic and international regulatory frameworks. Her role involves guiding the company through complex regulatory landscapes to ensure compliance and facilitate the approval of new therapeutics.
Extensive Experience in Regulatory and Quality Affairs
Kerry Wentworth has over 25 years of experience in Regulatory and Quality Affairs. Her career spans early and late-stage development across multiple therapeutic areas including oncology, osteoarthritis, pain management, autoimmune, and rare diseases. She has worked with a wide range of products, from injectable small molecules to complex autologous platforms, providing her with a broad and versatile skill set in the regulatory field.
Regulatory Leadership at Flexion Therapeutics
Before joining Nuvation Bio, Kerry Wentworth served as Chief Regulatory Officer for Flexion Therapeutics until it was acquired by Pacira Biosciences in 2021. Her leadership was pivotal in guiding Flexion Therapeutics' first New Drug Application (NDA) successfully through the FDA approval process, resulting in the product's commercialization. This achievement highlights her adeptness at navigating regulatory challenges to achieve significant milestones.
Vice President Role at Agenus, Inc.
Kerry Wentworth previously held the position of Vice President, Clinical, Regulatory, and Quality at Agenus, Inc. Her responsibilities included overseeing the regulatory and quality functions, ensuring that clinical developments met stringent regulatory standards. Her tenure at Agenus, Inc. further solidified her reputation as a leader in the regulatory affairs domain.
Educational Background in Pre-Veterinary Medicine
Kerry Wentworth holds a Bachelor of Science degree in pre-veterinary medicine from the University of New Hampshire. Her academic background provided a foundational understanding of medical sciences, which she has applied extensively throughout her regulatory and quality affairs career.